[go: up one dir, main page]

EP2493442A4 - Devices, methods, and composition for controlling infections - Google Patents

Devices, methods, and composition for controlling infections

Info

Publication number
EP2493442A4
EP2493442A4 EP10828816.8A EP10828816A EP2493442A4 EP 2493442 A4 EP2493442 A4 EP 2493442A4 EP 10828816 A EP10828816 A EP 10828816A EP 2493442 A4 EP2493442 A4 EP 2493442A4
Authority
EP
European Patent Office
Prior art keywords
composition
methods
devices
controlling infections
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP10828816.8A
Other languages
German (de)
French (fr)
Other versions
EP2493442A2 (en
Inventor
Paul J Rucinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innovation Technologies Inc
Original Assignee
Innovation Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovation Technologies Inc filed Critical Innovation Technologies Inc
Publication of EP2493442A2 publication Critical patent/EP2493442A2/en
Publication of EP2493442A4 publication Critical patent/EP2493442A4/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00Devices for applying media, e.g. remedies, on the human body
    • A61M35/003Portable hand-held applicators having means for dispensing or spreading integral media
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
EP10828816.8A 2009-10-26 2010-10-24 Devices, methods, and composition for controlling infections Ceased EP2493442A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25490609P 2009-10-26 2009-10-26
PCT/US2010/053884 WO2011056486A2 (en) 2009-10-26 2010-10-24 Devices, methods, and composition for controlling infections

Publications (2)

Publication Number Publication Date
EP2493442A2 EP2493442A2 (en) 2012-09-05
EP2493442A4 true EP2493442A4 (en) 2013-05-15

Family

ID=43970646

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10828816.8A Ceased EP2493442A4 (en) 2009-10-26 2010-10-24 Devices, methods, and composition for controlling infections

Country Status (5)

Country Link
EP (1) EP2493442A4 (en)
JP (1) JP2013508457A (en)
CN (1) CN102711709A (en)
CA (1) CA2778081A1 (en)
WO (1) WO2011056486A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5872430B2 (en) * 2012-09-20 2016-03-01 日本電子照射サービス株式会社 Chlorhexidine gluconate formulation, disinfection kit and sterilization method
US10016375B2 (en) 2013-12-12 2018-07-10 Paul J. Rucinski Materials and methods for controlling infections
RU2682642C1 (en) 2013-12-12 2019-03-20 Инновейшн Текнолоджиз, Инк. Materials and methods for controlling infections
WO2016022441A1 (en) * 2014-08-08 2016-02-11 Innovation Technologies, Inc. Materials and methods for controlling infections with negative pressure wound therapy

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165952A (en) * 1989-01-18 1992-11-24 Becton, Dickinson And Company Anti-infective and antithrombogenic medical articles and method for their preparation
US6017516A (en) * 1997-10-31 2000-01-25 Lekar Pharma Limited Pharmaceutical dental formulation for topical application of metronidazole benzoate and chlorhexidine gluconate
US20050191247A1 (en) * 2004-03-01 2005-09-01 David Drake Chlorhexidine compositions
US20070036846A1 (en) * 2005-08-15 2007-02-15 Tsang Wing W M Wound dressing and method of manufacture thereof
WO2008060380A2 (en) * 2006-10-18 2008-05-22 Arrow International, Inc. Anti-infective alcohol catheter solution with chlorhexidine treated catheter
WO2008077114A2 (en) * 2006-12-19 2008-06-26 Innovation Technologies, Inc. Devices and methods for delivering active agents to target sites

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616208D0 (en) * 1996-08-01 1996-09-11 Smithkline Beecham Plc Novel Compounds
US20040185028A1 (en) * 2003-03-19 2004-09-23 Zhenze Hu Antimicrobial compositions containing ethanolamine buffer and biguanide disinfectant
ES2303100T3 (en) * 2003-09-22 2008-08-01 Innovation Technologies, Inc. WOUND IRRIGATION DEVICE AND PROCEDURE.
US20050124946A1 (en) * 2003-12-05 2005-06-09 Sergio Landau Wound irrigation apparatus and method
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
JP2006117587A (en) * 2004-10-22 2006-05-11 Dainippon Sumitomo Pharma Co Ltd Germicidal disinfectant composition
US7540860B2 (en) * 2006-01-23 2009-06-02 Keith Stamler Wound irrigation splashback shield

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165952A (en) * 1989-01-18 1992-11-24 Becton, Dickinson And Company Anti-infective and antithrombogenic medical articles and method for their preparation
US6017516A (en) * 1997-10-31 2000-01-25 Lekar Pharma Limited Pharmaceutical dental formulation for topical application of metronidazole benzoate and chlorhexidine gluconate
US20050191247A1 (en) * 2004-03-01 2005-09-01 David Drake Chlorhexidine compositions
US20070036846A1 (en) * 2005-08-15 2007-02-15 Tsang Wing W M Wound dressing and method of manufacture thereof
WO2008060380A2 (en) * 2006-10-18 2008-05-22 Arrow International, Inc. Anti-infective alcohol catheter solution with chlorhexidine treated catheter
WO2008077114A2 (en) * 2006-12-19 2008-06-26 Innovation Technologies, Inc. Devices and methods for delivering active agents to target sites
KR20090106477A (en) * 2006-12-19 2009-10-09 이노베이션 테크놀로지스, 인코포레이티드 Apparatus and Methods for Delivering Active Agents to Target Sites
CN102727954A (en) * 2006-12-19 2012-10-17 技术革新公司 Device and method for delivering active agents to target sites

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Chlorhexidine andCetrimide IrrigationSolution", CONSUMER MEDICINE INFORMATION, September 1996 (1996-09-01), pages 1 - 2, XP002694789, Retrieved from the Internet <URL:http://www.betterhealth.vic.gov.au/bhcv2/bhcmed.nsf/ad41b722944269b34a256b4800020946/73f7a5de056f6bcbca257b3600107b78/$FILE/pucchcet.pdf> [retrieved on 20130404] *
CHAMBERS S T ET AL: "Reduction of exit-site infections of tunnelled intravascular catheters among neutropenic patients by sustained-release chlorhexidine dressings: results from a prospective randomized controlled trial", JOURNAL OF HOSPITAL INFECTION, ELSEVIER, AMSTERDAM, NL, vol. 61, no. 1, 1 September 2005 (2005-09-01), pages 53 - 61, XP004997429, ISSN: 0195-6701, DOI: 10.1016/J.JHIN.2005.01.023 *
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; October 2004 (2004-10-01), KANAZAWA KATSUNORI ET AL: "[Bactericial activity of chlorhexidine gluconate against recent clinical isolates of various bacterial species in Japan].", Database accession no. NLM15655906 *
KANAZAWA KATSUNORI ET AL: "[Bactericial activity of chlorhexidine gluconate against recent clinical isolates of various bacterial species in Japan].", THE JAPANESE JOURNAL OF ANTIBIOTICS OCT 2004, vol. 57, no. 5, October 2004 (2004-10-01), pages 449 - 464, ISSN: 0368-2781 *
VEENSTRA D L ET AL: "Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.", JAMA 20 JAN 1999, vol. 281, no. 3, 20 January 1999 (1999-01-20), pages 261 - 267, XP055349684, ISSN: 0098-7484 *

Also Published As

Publication number Publication date
CN102711709A (en) 2012-10-03
JP2013508457A (en) 2013-03-07
WO2011056486A2 (en) 2011-05-12
WO2011056486A3 (en) 2011-09-29
EP2493442A2 (en) 2012-09-05
CA2778081A1 (en) 2011-05-12

Similar Documents

Publication Publication Date Title
WO2011056650A9 (en) Methods and compositions for treating and preventing viral infections
GB2471806B (en) Compositions and methods for treating viral infections
ZA201208578B (en) Composition,method and use
AP3269A (en) Methods and compounds for treating paramyxoviridaevirus infections
IL225597A0 (en) Pharmaceutical composition, methods for treating and uses thereof
GB0917044D0 (en) Agents, uses and methods
GB0917054D0 (en) Agents, uses and methods
HUE048815T2 (en) Certain amino-pyrimidines, compositions thereof, and methods for their use
EP2560488A4 (en) Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
ZA201301598B (en) Benzoxaborole derivatives for treating bacterial infections
EP2527404A4 (en) Composition for ultraviolet ray-absorbable member, and ultraviolet ray-absorbable member comprising same
EP2445067A4 (en) Discharge-gap-filling composition, and electrostatic discharge-protector
GB0919591D0 (en) Controlling communications
GB0919592D0 (en) Controlling communications
SG2014010516A (en) Control gate
GB0919441D0 (en) Controlling bandwidth share
EP2424091A4 (en) Switching device and method for controlling same
ZA201108079B (en) Composition and method for controlling pests
GB201103931D0 (en) Printable composition, method and uses thereof
EP2493442A4 (en) Devices, methods, and composition for controlling infections
GB201005571D0 (en) Method, composition, article and uses
PH12012500528A1 (en) Compositions and methods for treating bacterial infections using caftaroline
PL2263454T3 (en) Treatment composition
HK1170928A (en) Devices, methods, and composition for controlling infections
IL216957A0 (en) Exo-s-mecamylamine method, use, and compound for treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120419

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1170928

Country of ref document: HK

RIC1 Information provided on ipc code assigned before grant

Ipc: A61M 31/00 20060101ALI20130404BHEP

Ipc: A61K 31/35 20060101ALI20130404BHEP

Ipc: A61M 25/00 20060101ALI20130404BHEP

Ipc: A61J 1/05 20060101AFI20130404BHEP

Ipc: A61L 2/18 20060101ALI20130404BHEP

Ipc: A61L 101/32 20060101ALI20130404BHEP

Ipc: A61M 35/00 20060101ALI20130404BHEP

Ipc: A61M 37/00 20060101ALI20130404BHEP

Ipc: A61P 31/00 20060101ALI20130404BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20130415

17Q First examination report despatched

Effective date: 20140527

APBK Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNE

APBN Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2E

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

APAV Appeal reference deleted

Free format text: ORIGINAL CODE: EPIDOSDREFNE

APBT Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9E

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20170901